Crewe Advisors’s LeMaitre Vascular LMAT Stock Holding History

Crewe Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7K	Sell	164 -45	-22%	-$4.61K	﹤0.01%	660
2026 Q1	$22.8K	Buy	209 +66	+46%	+$6.29K	﹤0.01%	496
2025 Q4	$11.6K	Buy	143 +15	+12%	+$1.29K	﹤0.01%	596
2025 Q3	$11.2K	Buy	+128	New	+$11.4K	﹤0.01%	609
2024 Q3	–	Sell	-253	Closed	-$20.8K	–	869
2024 Q2	$20.8K	Buy	253 +186	+278%	+$13.7K	﹤0.01%	545
2024 Q1	$4.45K	Buy	+67	New	+$4.13K	﹤0.01%	748
2023 Q2	–	Sell	-435	Closed	-$22.4K	–	962
2023 Q1	$22.4K	Hold	435	–	–	﹤0.01%	412
2022 Q4	$20K	Hold	435	–	–	﹤0.01%	424
2022 Q3	$22K	Hold	435	–	–	﹤0.01%	443
2022 Q2	$20K	Buy	+435	New	+$19.5K	﹤0.01%	419

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Crewe Advisors's LMAT Position: Q2 2026 in Review

Crewe Advisors reduced its LeMaitre Vascular (LMAT) stake by 22% in Q2 2026, selling an estimated $4.61K and leaving 164 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Crewe Advisors first reported a position in LMAT in Q2 2022 and has held it in 10 quarters since. The position peaked at $22.8K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Crewe Advisors held 164 shares of LeMaitre Vascular worth $15.7K as of Q2 2026.
Crewe Advisors sold 45 LeMaitre Vascular shares in Q2 2026, an estimated $4.61K.
LeMaitre Vascular made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #660 holding.
Crewe Advisors first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 10 quarters since.
Crewe Advisors's LeMaitre Vascular position peaked at $22.8K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.